Overview
Masakuni Serizawa practices in Shizuoka, Japan. Serizawa is highly rated in 4 conditions, according to our data. Their top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Chromosome 22 Duplication.
Their clinical research consists of co-authoring 69 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chromosome 22 DuplicationSerizawa isAdvanced. Learn about Chromosome 22 Duplication.
- Lung AdenocarcinomaSerizawa isAdvanced. Learn about Lung Adenocarcinoma.
- Lung CancerSerizawa isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- DysarthriaSerizawa isExperienced. Learn about Dysarthria.
- EGFR Positive Lung CancerSerizawa isExperienced. Learn about EGFR Positive Lung Cancer.
- Esophageal CancerSerizawa isExperienced. Learn about Esophageal Cancer.
- Familial Atypical Multiple Mole Melanoma Syndrome
- Familial Colorectal CancerSerizawa isExperienced. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerSerizawa isExperienced. Learn about Familial Pancreatic Cancer.